ArticleInfection and immunity2009

Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Subha Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.